Literature DB >> 22201532

Techniques for molecular imaging probe design.

Fred Reynolds1, Kimberly A Kelly.   

Abstract

Molecular imaging allows clinicians to visualize disease-specific molecules, thereby providing relevant information in the diagnosis and treatment of patients. With advances in genomics and proteomics and underlying mechanisms of disease pathology, the number of targets identified has significantly outpaced the number of developed molecular imaging probes. There has been a concerted effort to bridge this gap with multidisciplinary efforts in chemistry, proteomics, physics, material science, and biology--all essential to progress in molecular imaging probe development. In this review, we discuss target selection, screening techniques, and probe optimization with the aim of developing clinically relevant molecularly targeted imaging agents.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22201532      PMCID: PMC3224676     

Source DB:  PubMed          Journal:  Mol Imaging        ISSN: 1535-3508            Impact factor:   4.488


  155 in total

Review 1.  Small-molecule screening: advances in microarraying and cell-imaging technologies.

Authors:  Rebecca L Nicholson; Martin Welch; Mark Ladlow; David R Spring
Journal:  ACS Chem Biol       Date:  2007-01-23       Impact factor: 5.100

2.  A new type of synthetic peptide library for identifying ligand-binding activity.

Authors:  K S Lam; S E Salmon; E M Hersh; V J Hruby; W M Kazmierski; R J Knapp
Journal:  Nature       Date:  1991-11-07       Impact factor: 49.962

Review 3.  Aptamers: a new class of oligonucleotides in the drug discovery pipeline?

Authors:  Eric Dausse; Sonia Da Rocha Gomes; Jean-Jacques Toulmé
Journal:  Curr Opin Pharmacol       Date:  2009-08-28       Impact factor: 5.547

Review 4.  Can we prevent immunogenicity of human protein drugs?

Authors:  D W Scott; A S De Groot
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

5.  Utilization of multiple phage display libraries for the identification of dissimilar peptide motifs that bind to a B7-1 monoclonal antibody.

Authors:  P A De Ciechi; C S Devine; S C Lee; S C Howard; P O Olins; M H Caparon
Journal:  Mol Divers       Date:  1996-02       Impact factor: 2.943

6.  Quantitative affinity of genetically engineered repeating polypeptides to inorganic surfaces.

Authors:  Urartu O S Seker; Brandon Wilson; Deniz Sahin; Candan Tamerler; Mehmet Sarikaya
Journal:  Biomacromolecules       Date:  2009-02-09       Impact factor: 6.988

7.  The phosphotyrosine interaction domain of SHC recognizes tyrosine-phosphorylated NPXY motif.

Authors:  Z Songyang; B Margolis; M Chaudhuri; S E Shoelson; L C Cantley
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

8.  Comparison of N-terminal modifications on neurotensin(8-13) analogues correlates peptide stability but not binding affinity with in vivo efficacy.

Authors:  Kevin S Orwig; McKensie R Lassetter; M Kyle Hadden; Thomas A Dix
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

9.  Screening of cyclic peptide phage libraries identifies ligands that bind streptavidin with high affinities.

Authors:  L B Giebel; R T Cass; D L Milligan; D C Young; R Arze; C R Johnson
Journal:  Biochemistry       Date:  1995-11-28       Impact factor: 3.162

10.  DNA display I. Sequence-encoded routing of DNA populations.

Authors:  David R Halpin; Pehr B Harbury
Journal:  PLoS Biol       Date:  2004-06-22       Impact factor: 8.029

View more
  6 in total

1.  Quantitative Impact of Plasma Clearance and Down-regulation on GLP-1 Receptor Molecular Imaging.

Authors:  Liang Zhang; Greg M Thurber
Journal:  Mol Imaging Biol       Date:  2016-02       Impact factor: 3.488

2.  Detection of cannabinoid receptor type 2 in native cells and zebrafish with a highly potent, cell-permeable fluorescent probe.

Authors:  Thais Gazzi; Benjamin Brennecke; Kenneth Atz; Claudia Korn; David Sykes; Gabriel Forn-Cuni; Patrick Pfaff; Roman C Sarott; Matthias V Westphal; Yelena Mostinski; Leonard Mach; Malgorzata Wasinska-Kalwa; Marie Weise; Bradley L Hoare; Tamara Miljuš; Maira Mexi; Nicolas Roth; Eline J Koers; Wolfgang Guba; André Alker; Arne C Rufer; Eric A Kusznir; Sylwia Huber; Catarina Raposo; Elisabeth A Zirwes; Anja Osterwald; Anto Pavlovic; Svenja Moes; Jennifer Beck; Matthias Nettekoven; Irene Benito-Cuesta; Teresa Grande; Faye Drawnel; Gabriella Widmer; Daniela Holzer; Tom van der Wel; Harpreet Mandhair; Michael Honer; Jürgen Fingerle; Jörg Scheffel; Johannes Broichhagen; Klaus Gawrisch; Julián Romero; Cecilia J Hillard; Zoltan V Varga; Mario van der Stelt; Pal Pacher; Jürg Gertsch; Christoph Ullmer; Peter J McCormick; Sergio Oddi; Herman P Spaink; Mauro Maccarrone; Dmitry B Veprintsev; Erick M Carreira; Uwe Grether; Marc Nazaré
Journal:  Chem Sci       Date:  2022-04-01       Impact factor: 9.969

3.  Molecular imaging probe development: a chemistry perspective.

Authors:  Donald D Nolting; Michael L Nickels; Ning Guo; Wellington Pham
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-10

Review 4.  Molecular imaging in the era of personalized medicine.

Authors:  Kyung-Ho Jung; Kyung-Han Lee
Journal:  J Pathol Transl Med       Date:  2015-01-15

5.  Engineering agatoxin, a cystine-knot peptide from spider venom, as a molecular probe for in vivo tumor imaging.

Authors:  Sarah J Moore; Cheuk Lun Leung; Heidi K Norton; Jennifer R Cochran
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

6.  Mechanistic and quantitative insight into cell surface targeted molecular imaging agent design.

Authors:  Liang Zhang; Sumit Bhatnagar; Emily Deschenes; Greg M Thurber
Journal:  Sci Rep       Date:  2016-05-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.